跳至主要内容
临床试验/EUCTR2015-003238-29-ES
EUCTR2015-003238-29-ES进行中(未招募)1 期

Pilot phase II clinical trial, randomized, double-blind, controlled, single-center study to evaluate the efficacy and safety of Solanum malacoxylon 9CH in patients with calcific tendinitis of shoulder

Fundación Sociedad Española de Médicos de Atención Primaria (SEMERGEN)0 个研究点目标入组 104 人开始时间: 2015年12月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? Patients who have given written informed consent.
  • ? Patients of both sex with age ? 18 years in the screening visit.
  • ? Diagnosis of calcifying tendinitis of shoulder confirmed by image (standard radiography [Rx] and / or ultrasound in the 3 months prior to study treatment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 104
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 104

排除标准

  • ? Women pregnant or nursing.
  • ? Patients receiving homeopathic treatment.
  • ? Patients candidates for scheduled within 2 months following surgery.
  • ? Patients who have been treated with corticosteroids (oral or infiltrate) or invasive procedure (shock waves, ultrasound, etc.) in the past 3 months.
  • ? Patients who are unwilling or unable to comply with the protocol.

研究者

发起方
Fundación Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

相似试验